Surgeon-Anesthesiologist Collaboration
CCAP
Influence of Surgeon-anesthesiologist Collaboration on Patient Outcomes After Pheochromocytoma Surgery
1 other identifier
observational
1,122
1 country
1
Brief Summary
Collaboration between the surgeon and the anesthesiologist is key for delivering a safe pheochromocytoma surgery. This study aims to establish the collective performance of surgeon-anesthesiologist team by quantifying the relationship between their previous collaborations and patient complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 17, 2017
CompletedFirst Posted
Study publicly available on registry
May 18, 2017
CompletedStudy Start
First participant enrolled
July 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedMay 18, 2017
May 1, 2017
5 months
May 17, 2017
May 17, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Presence of an intraoperative hemodynamic instability
An intraoperative hemodynamic instability is defined as the occurrence of at least one intraoperative episode of systolic blood pressure ≥ 160 mmHg and at least one episode of mean blood pressure ≤ 60 mmHg
At the time of surgery (less than 4 hours)
Study Arms (1)
Pheochromocytoma
Patient who underwent surgical procedure for pheochromocytoma
Interventions
Assessment of the influence of surgeon-anesthesiologist collaboration on surgery complications during and up to 30 days after pheochromocytoma surgery.
Eligibility Criteria
Patients operated for pheochromocytoma
You may qualify if:
- All patients who underwent surgical procedure for pheochromocytoma in 8 French university hospitals from January 2000 to December 2016
You may not qualify if:
- Age \< 18 years old
- Patients operated for incidentaloma or with paraganglioma diagnosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pôle Information Médicale Evaluation Recherche des Hospices Civils de Lyon - Centre Hospitalier Lyon Sud
Pierre-Bénite, 69495, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 17, 2017
First Posted
May 18, 2017
Study Start
July 1, 2017
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
May 18, 2017
Record last verified: 2017-05
Data Sharing
- IPD Sharing
- Will not share